Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trigen Laboratories is a specialty pharmaceutical company that develops and markets generic and branded products, with a primary focus on nutritional supplements. The company's portfolio includes specialized treatments for iron deficiency and a comprehensive range of prenatal vitamins designed to support maternal and fetal health. Originally part of the Vertical/Trigen group, the company was later integrated into Osmotica Pharmaceuticals before being acquired by Alora Pharmaceuticals in 2021. Today, it operates as a key brand within the Alora/Avion Pharmaceuticals ecosystem, providing cost-effective therapeutic options for patients and healthcare providers. Its commercial offerings are centered on high-quality formulations that address specific nutritional gaps in patient care. The company maintains a strong presence in the U.S. market through its established distribution networks and partnerships with healthcare professionals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trigen Laboratory.